Upgrade to SI Premium - Free Trial

Tarsus Pharmaceuticals (TARS) PT Lowered to $97 at Oppenheimer

May 20, 2026 10:40 AM
Oppenheimer analyst Mazahir Alimohamed lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change